BioSpace News Archive

Business

CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business UpdateConference Call Scheduled for Today at 4:30 p.m. Eastern Time

CorMedix Inc. announced financial results for the third quarter and nine months ended September 30, 2019 and provided an update on recent business developments.

November 14, 2019
·
9 min read
Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences

Daniel Swisher, president and chief operating officer, will provide an overview of the company and a business and financial update.

November 14, 2019
·
2 min read
Drug Development

Oncternal Therapeutics Announces Presentation of Interim Clinical Data on TK216, its First-in-class, Targeted ETS Inhibitor, in Patients with Relapsed or Refractory Ewing Sarcoma at the CTOS 2019 Annual Meeting

Interim data from Phase 1 study in patients with Ewing sarcoma show TK216 has been generally well tolerated

November 14, 2019
·
9 min read
Business

Venus Concept Announces Third Quarter and First Nine Months of 2019 Financial Results

The information in this press release reflects the unaudited financial information for the three and nine months ended September 30, 2019 and September 30, 2018.

November 14, 2019
·
21 min read
Pharm Country

IVERIC bio to Host a Zimura® R&D Symposium for Investors / Analysts on November 20, 2019

IVERIC bio, Inc. announced details for its previously announced Zimura® R&D Symposium for Investors being held in New York, NY on Wednesday, November 20, 2019, from 8:00 a.m. to 10:00 a.m. ET.

November 14, 2019
·
2 min read
Pharm Country

Vaccinex Announces Award Notice from the Alzheimer’s Association 2020 Part the Cloud Program

Pepinemab (VX15), an experimental Vaccinex drug previously shown to prevent reduced brain glucose transport in Huntington’s disease, will be tested for similar effects in Alzheimer’s disease

November 14, 2019
·
5 min read
Business

Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress

Rubius Therapeutics, Inc. reported third quarter 2019 financial results and provided an overview of operational progress.

November 14, 2019
·
8 min read
Business

Spectral Announces Third Quarter 2019 Results

Spectral Medical Inc.,, a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, announced its unaudited financial results for the third quarter ended September 30, 2019.

November 14, 2019
·
7 min read
Biotech Bay

Atreca to Present at Two Upcoming Investor Conferences - Nov. 14, 2019

Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced that it will present at two upcoming investor conferences

November 14, 2019
·
1 min read
Business

Evofem Biosciences’ CEO Saundra Pelletier Awarded 2019 Business Woman Of The Year

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that Chief Executive Officer Saundra Pelletier was named a 2019 Business Woman of the Year by the San Diego Business Journal.

November 14, 2019
·
2 min read